X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

PHARMACOGENOMICS

期刊標題檢索 PHARMACOGENOMIC 最新評論: Additive effect refers to the effect of using two drugs together is eq... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[PHARMACOGENOMICS]您好,您是該頁面的第 21344 位訪客。

期刊簡介
期刊名稱PHARMACOGENOMICS PHARMACOGENOMICS
LetPub Score
5.2
50 ratings
Rate

Reputation
6.3

Influence
4.0

Speed
7.0

期刊簡稱PHARMACOGENOMICS
ISSN1462-2416
E-ISSN1744-8042
h-index83
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.400.4390.395
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q3194 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Genetics
Q3236 / 347
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q3129 / 178

自引率 (2023-2024)10.50%自引率趨勢
掲載範囲
Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field.

Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.
官方網站http://www.futuremedicine.com/loi/pgs
在線稿件提交http://www.futuremedicine.com/page/onlinesubmissions
開放訪問No
出版商Future Medicine Ltd.
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年0
每年文章數75每年文章數趨勢
黃金OA百分比11.16%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ3231/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1462-2416%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【PHARMACOGENOMICS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498329
    PHYTOMEDICINE340268
    LIFE SCIENCES285765
    International Journal of Pharmaceutics242440
    PHARMACOLOGICAL RESEARCH241283
    European Journal of Pharmacology204248
    BIOCHEMICAL PHARMACOLOGY202695
    JOURNAL OF NATURAL PRODUCTS196695
    BRITISH JOURNAL OF PHARMACOLOGY165141
    MOLECULAR PHARMACEUTICS162833
  •  

    PHARMACOGENOMICS PHARMACOGENOMICS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [PHARMACOGENOMICS] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:19:33 評論於
Additive effect refers to the effect of using two drugs together is equal to the effect of using double the dose of each drug individually. If the therapeutic effect obtained from the combination of two drugs is greater than the sum of the effects of the two drugs used individually, it is called a synergistic effect
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:37:05 評論於
4-6 pictures
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 23:10:36 評論於
How many figures/tables are usually required by regular journals?
(0) 讚! | 修然小公主

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 13:23:47 評論於
What is synergy? What is additive effect? What is the difference between the two?
(0) 讚! | 龙鳞孝礼

作者: 平原笑柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-12 21:44:39 評論於
Hello, is this an OA journal?
(0) 讚! | 平原笑柳

作者: Alma Newton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-15 20:41:58 評論於
Review Speed: 1.0
Experience Sharing: Submitted at the end of November, first review took one month, revised for second review at the end of December, accepted in mid-May, published online in June. Editor was very kind, submission process took six months
(0) 讚! | Alma Newton

作者: 新瑶少女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-06 12:59:28 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0
Focused research areas: Pharmacogenomics
Experience sharing: Submitted on November 13, 2019, revised on February 13, 2020, revised again on May 23, 2020, accepted in July. Overall, it is acceptable. No publication fee or page charges
(0) 讚! | 新瑶少女

作者: 奉天俊强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-06 23:40:52 評論於
The journal has been downgraded to Tier 4 in the latest 2020 ranking by the Chinese Academy of Sciences
(0) 讚! | 奉天俊强

作者: 奉天俊强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-25 16:49:52 評論於
Published yesterday
(0) 讚! | 奉天俊强

作者: 奉天俊强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-12 21:48:29 評論於
I am working on a research-based original paper
(0) 讚! | 奉天俊强

作者: Alma Newton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-06 17:11:58 評論於
Can this magazine only accept reviews? The style they accept for publication seems really strange
(0) 讚! | Alma Newton

作者: 奉天俊强


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-28 17:14:38 評論於
Review speed: 3.0 | Submission acceptance rate: 75.0 Experience sharing: Just received a submission, first review took about four months, minor revisions in the first round of feedback, accepted immediately after revision, still a very friendly journal
(0) 讚! | 奉天俊强

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 19:17:57 評論於
The continuous decline, if it continues, will it break 2? In just one year, it has fallen quite a bit, even 0.1 point should be cherished
(0) 讚! | 凌霄高洁

作者: Osborn Walpole


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-05-11 22:21:17 評論於
Review speed: 3.0 | Submission success rate: 25.0
Experience sharing: High language requirements, plagiarism check will be conducted
(0) 讚! | Osborn Walpole

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-03-22 15:33:46 評論於
First review, over two months; second review, within one month; waiting for proof, four months. The editor-in-chief is very nice. The article needs to be very rigorous, including rigorous and meticulous verification of experiments and language wording
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 13:43:16 評論於
Focused research direction: Genomics
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-12-29 09:12:01 評論於
I have reviewed two articles for this magazine, both have been rejected
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [PHARMACOGENOMICS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*